Iomeron (Iomeprol)

Iomeprol is an iodinated, non‑ionic compound that absorbs X‑ray photons. After injection, it distributes in the extracellular fluid, increasing the radiodensity of blood vessels, joint spaces, or cerebrospinal fluid, which creates a clear contrast between structures on CT, fluoroscopy, or digital subtraction imaging.

The dose of Iomeron is individualized by the prescribing physician based on the type of examination, patient size, renal function, and the specific imaging protocol. The healthcare provider calculates the appropriate volume and concentration to achieve optimal contrast while minimizing risk.

Safety data for Iomeron in pregnancy and lactation are limited. It is generally avoided unless the diagnostic benefit outweighs potential risks. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives and risk assessment with their physician before administration.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Iomeron. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Iomeron is a non‑ionic, low‑osmolality iodinated contrast medium, offering a lower incidence of adverse reactions compared with older high‑osmolality agents. Compared with other low‑osmolality agents, its safety profile and image quality are comparable, while formulation differences may affect viscosity and injection rates.

Iomeron should be stored below 25 °C in its original sealed container, protected from light and moisture. Do not freeze the solution, and avoid shaking. Before use, inspect the vial for particulate matter or discoloration and allow it to reach room temperature if refrigerated.

Iomeron is supplied as a sterile solution for injection and is administered intravenously, intra‑arterially, intra‑articularly, or intrathecally by a trained healthcare professional. The injection is performed using aseptic technique, and the volume is adjusted to the specific imaging protocol and patient characteristics.

The most serious risks include severe allergic reactions such as anaphylaxis, contrast‑induced nephropathy leading to acute kidney injury, and rare cardiovascular events like severe hypotension or arrhythmias. Prompt recognition and management of these reactions are essential during and after administration.

Iomeron is contraindicated in patients with a known hypersensitivity to iodinated contrast media, a history of severe allergic reactions to similar agents, uncontrolled hyperthyroidism, or severe renal impairment where alternative imaging is feasible. Clinicians should evaluate each patient’s medical history before use.